Good afternoon :)
Place Order
Add to Watchlist

Remus Pharmaceuticals Ltd

REMUS

Remus Pharmaceuticals Ltd

REMUS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,546 cr, stock is ranked 1,289
High RiskStock is 4.47x as volatile as Nifty
2,571.750.19% (+4.90)
2,571.750.19% (+4.90)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,546 cr, stock is ranked 1,289
High RiskStock is 4.47x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,546 cr, stock is ranked 1,289
High RiskStock is 4.47x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
14.82
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.906.610.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Remus Pharmaceuticals Ltd markets and distributes pharmaceutical formulations and active pharmaceutical ingredients, specializing in various therapeutic areas including oncology and cardiovascular health.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2024TTM
Total Revenue217.90
Raw Materialssubtract164.99
Power & Fuel Costsubtract0.00
Employee Costsubtract7.42
Selling & Administrative Expensessubtract5.25
Operating & Other expensessubtract7.02
Depreciation/Amortizationsubtract0.90
Interest & Other Itemssubtract0.48
Taxes & Other Itemssubtract10.30
EPS36.56
DPS0.00
Payout ratio0.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Remus Pharmaceuticals Ltd71.7914.82
Sun Pharmaceutical Industries Ltd45.106.440.75%
Cipla Ltd29.414.520.87%
Torrent Pharmaceuticals Ltd68.5016.550.84%

Price Comparison

Compare REMUS with any stock or ETF
Compare REMUS with any stock or ETF
REMUS
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.84%0.00%0.77%3.16%25.22%

Sep 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

MarMaySepMarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

REMUS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateNov 19, 2024

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 19, 2024

Cash Dividend

Ex DateEx DateMay 2, 2024

Interim 2
Interim 2 | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

May 2, 2024

Cash Dividend

Ex DateEx DateOct 27, 2023

Interim
Interim | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Oct 27, 2023

Cash Dividend

Ex DateEx DateSep 15, 2023

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 15, 2023

News & Opinions
Corporate
Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9 November 2024, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live